Literature DB >> 34515246

Does the Side Matter? A Retrospective Cohort Study Comparing Left and Right Pure Laparoscopic Donor Nephrectomies.

Philip Zeuschner1, Michael Stöckle1, Robert Peters2, Kurt Miller2, Lutz Liefeldt3, Fabian Halleck3, Klemens Budde3, Linda Hennig3, Frank Friedersdorff3,4.   

Abstract

OBJECTIVES: Right laparoscopic donor nephrectomy (RLDN) is no longer regarded inferior to left LDN (LLDN). However, this knowledge is based on many studies suffering from inherent learning curves, center-specific imbalances, and different laparoscopic techniques.
METHODS: Pure LDNs at a high-volume referral center from 2011 to 2016 were retrospectively analyzed. Patient, graft characteristics, outcomes of LDNs, and corresponding open kidney transplantations were compared between LLDN and RLDN including a follow-up.
RESULTS: 160 (78.4%) LLDNs and 44 (21.6%) RLDNs only differed regarding graft characteristics, as more right grafts had multiple veins (34.1 vs. 6.9%, p < 0.001) and worse scintigraphic function (44 vs. 51%, p < 0.001). RLDNs were shorter (201 vs. 220 min, p = 0.032) with longer warm ischemia time (165 vs. 140 s, p < 0.001), but left grafts were transplanted faster (160 vs. 171 min, p = 0.048). Recipients of right kidneys had more postoperative complications (grade 3: 25.6 vs. 11.3%, p = 0.020). At a follow-up of 45 (range 6-79) months, neither the kidney function, nor death-censored graft (5-year: LLDN 89 vs. 92%, p = 0.969) and patient survival (5-year: LLDN 95 vs. 98%, p = 0.747) differed.
CONCLUSIONS: Pure LLDN and RLDN can have different outcomes at high-volume centers, especially higher complications for recipients of right grafts. However, long-term function and graft survival are the same irrespective of the chosen side.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Laparoscopic donor nephrectomy; Living kidney donation; Minimally invasive surgery

Mesh:

Year:  2021        PMID: 34515246     DOI: 10.1159/000517882

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone.

Authors:  Haojie Chen; Bowen Shi; Yanyuan Wu; Yuhang Qian; Jiatong Zhou; Xi Zhang; Jie Ding; Yongjiang Yu
Journal:  Int Urol Nephrol       Date:  2022-02-24       Impact factor: 2.370

Review 2.  Acute kidney injury and the compensation of kidney function after nephrectomy in living donation.

Authors:  Kenji Okumura; Holly Grace; Hiroshi Sogawa; Shigeyoshi Yamanaga
Journal:  World J Transplant       Date:  2022-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.